Study to target treatment of CF patients

A study aimed at tailoring cystic fibrosis (CF) treatment to each patient’s particular infection at any one time will begin in Ireland and internationally in the coming years.

At present, when a CF patient acquires a respiratory infection, they are given a more general antibiotic. There are fears this approach has built up patient resistance to antibiotic treatment.

Ireland has the highest rate of CF per head of population in the world. Internationally, the median age for a CF patient to die is between the ages of 32 and 38.